Cargando…
Treatment of Metastatic Primary Extramammary Paget Disease With Combination Anlotinib and Tislelizumab: A Case Report and Review of the Literature
Extramammary Paget’s disease (EMPD) is a rare cutaneous neoplasm with distant metastases and a poor prognosis. We report the case of a 63-year-old male patient exhibiting stage IV primary EMPD with neuroendocrine differentiation, and harboring a somatic mutation in AMER1. After four cycles of Anloti...
Autores principales: | Yin, Xin, Li, Xiaoqing, Li, Muli, She, Qing, Liu, Yan, Chen, Xiaodan, Ma, Suhua, Ma, Qian, Huang, Zhangkan, Xu, Lin, Huang, Xiaozhun, Zhan, Zhengyin, Che, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170962/ https://www.ncbi.nlm.nih.gov/pubmed/35685408 http://dx.doi.org/10.3389/fmed.2022.891958 |
Ejemplares similares
-
The Outcome of Chemotherapy for Metastatic Extramammary Paget’s Disease
por: Hashimoto, Hiroki, et al.
Publicado: (2021) -
Extramammary Paget’s disease
por: Vasquez, Andres, et al.
Publicado: (2016) -
Extramammary Perianal Paget's Disease
por: Al Hallak, M.N., et al.
Publicado: (2009) -
Mammary and extramammary Paget's disease()
por: Lopes, Lauro Lourival, et al.
Publicado: (2015) -
Metastatic Extramammary Paget’s Disease: Pathogenesis and Novel Therapeutic Approach
por: Fukuda, Keitaro, et al.
Publicado: (2018)